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IKK Provides an Essential Link between
RANK Signaling and Cyclin D1 Expression
during Mammary Gland Development
tions constitutively activate NF-B2 (another NF-B
component) and were linked to lymphomas (Gilmore et
al., 1999; Neri et al., 1991). Elevated NF-B DNA binding
activity was detected in a variety of tumors (Gilmore et
al., 1999), including hormone-dependent and -indepen-
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dent human breast cancers, as well as chemically in-Signal Transduction
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causative role in tumor development. NF-B activity isLa Jolla, California 92093
also induced during normal mammary gland develop-2 Molecular Biology Section
ment (Clarkson et al., 2000; Geymayer and Doppler,Division of Biology
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The mammary gland is an ideal system for studying9500 Gilman Drive
the control of organogenesis, and it offers an opportu-La Jolla, California 92093
nity to probe the potential role of NF-B in this process.3 Massachusetts General Hospital Cancer Center
Mammary gland development is a highly regulated pro-and the Children’s Service
cess (Hennighausen and Robinson, 2001). Briefly, atMassachusetts General Hospital
birth, the mammary epithelium consists of a simple net-Building 149, 13th Street
work of ducts that occupy a minor portion of the mam-Charlestown, Massachusetts 02129
mary fat pad. During puberty, ductal outgrowth rapidly
increases through a balance between proliferation and
apoptosis that occurs in structures known as terminalSummary
end buds. Most epithelial growth, however, occurs dur-
ing pregnancy and involves extensive and rapid prolifer-To identify functions of the IKK subunit of IB kinase
ation and side branching of the mammary epitheliumthat require catalytic activity, we generated an IkkAA
into a complex tree of lobuloalveolar units. At lactation,knockin allele containing alanines instead of serines
the epithelial cells undergo terminal differentiation andin the activation loop. IkkAA/AA mice are healthy and
begin to secrete milk. During involution, the majority offertile, but females display a severe lactation defect
the epithelial network regresses in size through apo-due to impaired proliferation of mammary epithelial
ptosis and tissue remodeling to a structure that resem-cells. IKK activity is required for NF-B activation
bles the gland of a nulliparous female. NF-B is activatedin mammary epithelial cells during pregnancy and in
during pregnancy, peaking around days 15–16 post coi-response to RANK ligand but not TNF. IKK and NF-
tum, and during involution (Clarkson et al., 2000; Gey-B activation are also required for optimal cyclin D1
mayer and Doppler, 2000). The exact role of NF-B ininduction. Defective RANK signaling or cyclin D1 ex-
mammary gland development is not clear, and it waspression results in the same phenotypic effect as the
suggested to either maintain the proliferative state ofIkkAA mutation, which is completely suppressed by a
lobuloalveolar cells, prevent their terminal differentia-mammary specific cyclin D1 transgene. Thus, IKK
tion, or delay the onset of apoptosis.is a critical intermediate in a pathway that controls
The signaling pathway responsible for NF-B activa-
mammary epithelial proliferation in response to RANK
tion during mammary gland development is not known
signaling via cyclin D1. either. Usually, NF-B activity is regulated through inter-
action with specific inhibitors, IBs, which trap NF-B
Introduction dimers in the cytoplasm (Ghosh et al., 1998). In response
to cell stimulation with proinflammatory and innate im-
NF-B transcription factors are well established critical mune stimuli, such as TNF, interleukin 1 (IL-1), or bacte-
regulators of innate and adaptive immune responses as rial endotoxin (LPS), the IBs are phosphorylated at two
well as inflammation (Delhase and Karin, 1999; Ghosh conserved serines and targeted to rapid ubiquitin-
et al., 1998). Substantial evidence suggests that NF-B dependent proteolysis (Karin and Ben-Neriah, 2000). IB
may also be involved in carcinogenesis (Gilmore et al., phosphorylation is carried out by the IB kinase (IKK),
1999). Activation of NF-B inhibits apoptosis by tumor a complex composed of three subunits: IKK, IKK, and
necrosis factor (TNF) and various anticancer drugs and IKK/NEMO (Rothwarf and Karin, 1999). IKK and IKK
radiation (Delhase and Karin, 1999). NF-B activation serve as the catalytic subunits, whereas IKK/NEMO is
may also promote cell proliferation (Bargou et al., 1997; the regulatory subunit. IKK and IKK contain very simi-
Guttridge et al., 1999; Hinz et al., 1999). The c-rel gene, lar kinase domains with essentially identical activation
encoding a component of NF-B, is the cellular homolog loops (Mercurio et al., 1997; Woronicz et al., 1997; Zandi
of the v-rel oncogene. These chromosomal transloca- et al., 1997). Despite their structural and biochemical
similarities, IKK and IKK are functionally distinct
(Rothwarf and Karin, 1999). Whereas IKK is essential4 Correspondence: karinoffice@ucsd.edu
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for NF-B activation in response to proinflammatory and suggested that IKK might be involved in a different
signaling pathway. To identify such a function of IKKinnate immune stimuli, IKK is not required for such
responses (Hu et al., 1999; Li et al., 1999a, 1999b; Senft- in vivo, we generated a mouse mutant expressing IkkAA
instead of the wt allele in all tissues.leben et al., 2001a; Tanaka et al., 1999). IKK, however,
plays a unique and critical role in development of the To replace serines 176 and 180 of IKK with alanines,
a NotI site was introduced into the seventh intron of Ikk,epidermis (Hu et al., 1999; Takeda et al., 1999), but its
ability to induce keratinocyte differentiation is indepen- into which a loxP-flanked Neor cassette was inserted
(Figure 1A). Serine to alanine substitutions were intro-dent of its protein kinase activity or NF-B (Hu et al.,
2001). Recently, IKK was found to be required for B duced by site-directed mutagenesis, which also created
an Eco47III site. A targeting vector containing these al-cell maturation, another unique function that is not pro-
vided by IKK (Kaisho et al., 2001; Senftleben et al., terations was electroporated into ES cells, and six
clones with homologous recombination at the Ikk locus2001b). This function is dependent on IKK kinase activ-
ity, but instead of being mediated through inducible IB were selected for electroporation with a plasmid ex-
pressing Cre recombinase to remove the Neor cassette.degradation, is exerted via a second NF-B activation
pathway, dependent on processing of the NF-B2/p100 A heterozygous Ikk/AA ES clone was selected and in-
jected into mouse blastocysts, yielding chimeric mice,precursor to the mature p52 subunit (Senftleben et al.,
2001b). This pathway requires the activity of another which transmitted the mutant allele. The F2 generation
was genotyped by PCR analysis of tail DNAs using allele-protein kinase, NIK (NF-B inducing kinase), which may
function as an activator of IKK (Senftleben et al., 2001b; specific primers and confirmed by Eco47III digestion
(Figure 1B). The frequency of Ikk/:Ikk/AA:IkkAA/AAYin et al., 2001).
One receptor-ligand pair that could mediate NF-B mice was approximately 1:2:1, as expected based on
Mendelian inheritance (data not shown). RT-PCR analy-activation during mammary gland development consists
of RANK (receptor activator of NF-B), a member of the sis demonstrated expression of the IkkAA allele (Figure
1C), confirmed by sequencing of PCR products (dataTNF receptor (TNFR) family and RANK ligand (RANKL,
also known as OPGL, ODF, and TRANCE), a member not shown). IkkAA/AA mice were normal from birth until
adulthood and largely indistinguishable from their wt orof the TNF family (Fata et al., 2000). As its namesake
indicates, RANK is an efficient NF-B activator (Ander- heterozygote littermates in weight, size, appearance,
development, fertility, and behavior. In contrast toson et al., 1997). Although RANK and RANKL were origi-
nally characterized as playing important roles in lympho- Ikk/ mice (Hu et al., 1999), IkkAA/AA mice showed no
defects in skin or limb development (data not shown).cyte and osteoclast differentiation and activation (Kong
et al., 1999), they were recently found to be essential To examine whether IKK kinase activity contributes
to IKK or NF-B activation by proinflammatory cyto-for mammary gland development (Fata et al., 2000). The
biochemical pathway by which RANK controls mam- kines, embryonic fibroblasts (MEF) were treated with
TNF or IL-1. IkkAA/AA MEFs did not show any defectsmary gland development has not been defined.
To identify functions of IKK that depend on its protein in IKK (Figure 1D) or NF-B (Figure 1E) activation. IKK
and NF-B activation also proceeded normally inkinase activity, we generated a knockin IkkAA allele in
which the activation loop serines, whose phosphoryla- IkkAA/AA mice administered LPS (data not shown). This
data is consistent with previous results, affirming thattion is required for kinase activation (Delhase et al., 1999;
Mercurio et al., 1997), were replaced with alanines. IKK is the major catalytic subunit responsible for IKK
and NF-B activation by proinflammatory stimuli.IkkAA/AA mice are viable, healthy, fertile, and morphologi-
cally normal. However, IkkAA/AA females display a severe
lactation defect due to defective proliferation of the IKK Is Essential for Lactation and Lobuloalveolar
lobuloalveolar tree during pregnancy. Analysis of these Development during Pregnancy
defects revealed that IKK is required for NF-B activa- IkkAA/AA females completed pregnancy and gave birth
tion in the mammary epithelium during pregnancy and to pups whose size and numbers were normal. However,
in response to RANKL application. NF-B activation is all pups born to IkkAA/AA mothers died within 1–2 days,
required for optimal induction of cyclin D1, whose abla- despite normal nursing. Examination of the pups’ stom-
tion results in a mammary gland defect similar to the one achs revealed no milk. This phenotype was specific to
displayed by Rank/, Rankl/, or IkkAA/AA mice (Fantl et IkkAA/AA mothers and was independent of pup genotype.
al., 1995; Sicinski et al., 1995). Accordingly, a mammary- When cross-fostering experiments were performed, no
gland-specific cyclin D1 transgene completely rescues pups survived with IkkAA/AA mothers, while pups nursed
the lactation defect in IkkAA/AA mice. by Ikk/AA or wt mothers did (data not shown). These
results confirmed that IkkAA/AA mothers have a specific
lactation defect that caused the lethality of their off-Results
spring. This defect was exhibited even after multiple
pregnancies (at least 10), indicating that loss of IKKGeneration of IkkAA/AA Knockin Mice
Activation of IKK requires phosphorylation of serines kinase activity is not compensated by multiple expo-
sures to pregnancy hormones.177 and 181 in its activation loop (Delhase et al., 1999;
Mercurio et al., 1997). The same serines that are present Whole-mount analysis of mammary glands demon-
strated that IkkAA/AA virgin females completed normalin IKK, in principle, should be required for its activation.
Surprisingly, however, an S176A, S180A mutant of IKK ductal development (Figure 2A). Examination on day 1
after delivery (L1), however, revealed that the lobuloal-(IkkAA) still supports TNF- or IL-1- mediated IKK activa-
tion in HeLa cells (Delhase et al., 1999). These results veolar network in IkkAA/AA mammary glands was se-
IKK and Mammary Gland Development
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Figure 1. Generation of IkkAA Mutant Mice
(A) The IkkAA targeting vector and the targeted locus after homologous recombination. Solid boxes – exons, lines – introns, solid triangles –
loxp sites. Neor cassette was inserted in the opposite orientation to the Ikk transcription unit.
(B) Genotyping of F2 mice by PCR analysis of tail DNAs. A forward primer (p392, specific for exon 5) was used in combination with either
pWT, a primer specific for the wt sequence (S176, S180), pAA, a primer specific for the mutated sequence (A176, A180), and p776, a primer
for exon 7, followed by Eco47III digestion.
(C) Total liver RNA was converted to cDNA and amplified using primers p392 and p776 (top panel). Lane 1, genomic DNA was used as
template; Lane 2, Ikk cDNA was used as a template. PCR products were digested with Eco47III to reveal the presence of the mutant sequence
(bottom panel).
(D) IB kinase activity in wt and mutant fibroblasts. Primary MEFs were left untreated or stimulated for 15 min with mouse TNF (20 ng/ml)
or IL-1 (10 ng/ml). IKK complexes were immunoprecipitated with anti-IKK and associated kinase activity determined with GST-IB (1–54)
as a substrate.
(E) Induction of NF-B DNA binding activity in wt and mutant fibroblasts. Primary MEFs were stimulated with TNF for the indicated times
and NF-B and NF-1 DNA binding activities were examined by electrophoretic mobility shift assay (EMSA).
verely underdeveloped. Minimal side branching and al- (Figure 2C), suggesting that the differentiation process is
not blocked. In summary, the extensive lobuloalveolarveoli sprouting of ducts were observed; the extent of
alveolar development was comparable to that of wt development that occurs during pregnancy is severely
impaired in IkkAA/AA mice. Notably, mammary gland de-mammary glands at 10 days of pregnancy (P10; Figure
2A). Histological analysis confirmed the failure of proper velopment in IkkAA/AA females seems normal during duc-
tal morphogenesis.lobuloalveolar development in IkkAA/AA mammary glands
(Figure 2B). The number of secretory alveoli was dramat- Proper mammary gland development requires hor-
monal stimulation and epithelial stromal interactionically reduced in comparison to wt glands of same devel-
opmental age. In addition, the alveoli of IkkAA/AA glands (Hennighausen and Robinson, 2001). To determine
whether the developmental defect of IkkAA/AA mice waswere small with small or closed lumina. However, milk
protein genes were activated in IkkAA/AA mammary intrinsic to the mammary epithelium or due to either
hormonal insufficiency or stromal cell defects, we per-glands, although at slightly lower levels relative to the wt
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Figure 2. Impaired Lobuloalveolar Development in IkkAA/AA Mammary Glands
Whole-mount (A) and histological analyses by H&E staining (B) of wt and mutant mammary glands at different developmental stages. V-6
week, 6 week old virgin; V-8 week, 8 week old virgin; P10, day 10 of pregnancy; L1, day 1 of lactation.
(C) Expression of milk protein genes. Total RNA extracted from wt and mutant mammary glands at different time points was analyzed by
Northern hybridization for expression of -casein and WAP mRNAs. CK18 is an epithelial specific marker. Two animals are shown for each
genotype and time point.
(D) The developmental defect is intrinsic to the IkkAA/AA mammary epithelium. Mammary glands isolated from wt and IkkAA/AA donors were
IKK and Mammary Gland Development
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formed transplantation experiments. Small pieces of not shown). Similar results were revealed by immunoblot
analysis, which showed approximately 2-fold reductionmammary gland tissue taken from wt or IkkAA/AA donors
were implanted into cleared fat pads of 3-week-old in cyclin D1 levels at either P6 or P10 and a 5-fold
reduction at L1 in IkkAA/AA mammary glands (Figure 4B).Rag1/ recipients. These mice were mated 9 weeks
later and mammary glands were analyzed shortly after Similar results were obtained by RNA and microarray
analyses, which failed to reveal reduced expression ofdelivery. Transplanted wt epithelia showed lobuloal-
veolar development similar to the internal control, while other cell cycle regulators (data not shown). These re-
sults suggest that the proliferation defect in the IkkAA/AAtransplanted IkkAA/AA epithelia failed to develop proper
lobuloalveolar structures (Figure 2D). Hence, the devel- mammary epithelium is due to reduced cyclin D1 ex-
pression.opmental defect of IkkAA/AA mice is autonomous to the
mammary epithelium.
Defective NF-B Activation in IkkAA/AA
Lactation Defect Is due to Impaired Epithelial
Mammary Glands
Cell Proliferation
NF-B DNA binding activity is induced during pregnancy
To determine whether the mammary development de-
(Clarkson et al., 2000; Geymayer and Doppler, 2000),
fect was the result of reduced cell proliferation or in-
and cyclin D1 was suggested to be an NF-B target
creased cell death, BrdU incorporation and TUNEL
gene (Guttridge et al., 1999; Hinz et al., 1999). It therefore
assays were performed. Wt and IkkAA/AA females at ei-
seemed possible that reduced cyclin D1 expression in
ther P10 or L1 were administered BrdU, whose incorpo-
IkkAA/AA mammary glands may be caused by an NF-B
ration into DNA was detected by immunohistochemistry
activation defect. Indeed, NF-B activation in IkkAA/AA
(Figure 3A). The proliferation index was calculated as
mammary glands was almost completely diminished be-
a percentage of BrdU-positive alveolar cells per total
tween P6 and L1 (Figure 5A). Western blot analysis,
epithelial cells (Figure 3B). At P10, the proliferation rate
however, revealed similar levels of NF-B proteins, in-
in the IkkAA/AA mammary epithelium was approximately
cluding RelA (p65), RelB, c-Rel, and NF-B1 p105 and
half of the wt rate (7.4% versus 12.8%). At L1, the defect
p50 in wt and IkkAA mammary glands at P10 (Figure
was even more dramatic (0.9% versus 5.7%). Most of
5B). Consistent with previous results (Senftleben et al.,
the decrease in the proliferation rate was due to reduced
2001b), processing of NF-B2 p100 into mature p52 was
proliferation of lobuloalveolar cells, as the small number
defective in IkkAA/AA mammary glands (Figure 5B). It
of BrdU-positive ductal cells was relatively unchanged.
should be noted, however, that the total level of NF-B2
As the number of epithelial cells was greatly reduced in
in mammary glands is low, unlike the situation in B cells
mutant glands, the actual decrease in lobuloalveolar
(Senftleben et al., 2001b), and no p52 could be detected
proliferation may be even more dramatic than shown by
even in wt NF-B complexes, which were mostly
the normalized values. Similar results were obtained by
p65:p50 heterodimers (data not shown).
staining sections of wt and IkkAA/AA tissues with antibod-
ies to proliferating cell nuclear antigen (PCNA), a marker
for S phase cells (Figure 3A). The number of PCNA- RANKL Activates NF-B in wt but Not IkkAA/AA
positive cells in the IkkAA/AA mammary epithelium at P10 Mammary Epithelial Cells
was 50% lower than in the wt. On the other hand, there Defective mammary gland development, as exhibited
were no significant differences in the apoptosis rates, by IkkAA/AA and cyclin D1/ females, is exhibited by
measured by TUNEL assay, between wt and IkkAA/AA female mice lacking RANKL (OPGL/TRANCE/ODF) or its
mammary glands at either P10 or L1 (data not shown). receptor RANK (Fata et al., 2000). RANK ligation results
Very few apoptotic cells could be detected at either in NF-B activation (Anderson et al., 1997). It is therefore
time point. These results strongly suggest that IKK is possible that the defect in mammary gland development
essential for proliferation of the lobuloalveolar epithe- caused by the IkkAA/AA mutation is due to either dimin-
lium in response to pregnancy signals. ished RANKL or RANK expression or defective RANK
signaling. Northern blot analysis indicated that RANKL
mRNA was actually elevated in IkkAA/AA mammaryDefective Cyclin D1 Induction in IkkAA/AA
Mammary Glands glands between P6 and P15 (Figure 6A). The levels of
RANK mRNA examined by RT-PCR analysis were verySince cyclin D1 is the major G1 cyclin expressed in
mammary epithelial cells and cyclin D1/ females ex- similar in wt and IkkAA/AA mammary epithelial cells (Fig-
ure 6B). To examine RANK signaling in wt and IkkAA/AAhibit a similar defect in mammary gland development
as IkkAA/AA females (Fantl et al., 1995; Sicinski et al., mammary epithelial cells, we cultured these cells using
an established procedure (Pullan and Streuli, 1997) and1995), we examined cyclin D1 expression in wt and
IkkAA/AA mammary glands. Immunohistochemical analy- stimulated them with recombinant RANKL or TNF.
While TNF induced NF-B DNA binding and IKK activi-sis revealed that at P10 only 20.0% of the IkkAA/AA mam-
mary epithelial cells were cyclin D1 positive versus ties in both wt and IkkAA/AA epithelial cells, RANKL in-
duced NF-B DNA binding (p65:p50 heterodimers) and42.4% of the wt cells (Figure 4A). At L1, the reduction
in cyclin D1 expression was even more dramatic (data IKK activities in wt but not IkkAA/AA cells (Figures 6C and
transplanted into the cleared fat pads of the fourth mammary gland of Rag1/ mice. After 9 weeks, the recipients were impregnated and their




Figure 3. Impaired Epithelial Proliferation in
IkkAA/AA Mammary Glands
(A) BrdU incorporation and PCNA staining.
BrdU was administered at P10 or L1, and the
mammary glands were removed 2 hr later.
Paraffin sections of P10 glands were stained
with anti-BrdU or anti-PCNA antibodies. Pos-
itive cells were visualized with Cyanine 3 (red).
Nuclei were counter-stained with DAPI (blue).
(B) BrdU labeling indices. 300-400 epithelial
cell nuclei were examined per section of wt
and IkkAA/AA glands. The values represent the
average fraction of BrdU-positive epithelial
cells per total number of epithelial cells of
three different mice.
D). These results were obtained at least three times with revealed defective lobuloalveolar development in line
13 but not in line 6 (Figure 7B). Although both lines weredifferent primary cultures.
positive for MMTV-IbA32/36 DNA (Figure 7C), expression
of the transgene was considerably higher in line 13 (Fig-Inhibition of NF-B Activity in Mammary Glands
ure 7D). Correspondingly, expression of cyclin D1 wasInhibits Their Development
reduced in line 13 but not in line 6 mammary glandsTo assess whether the developmental defect in IkkAA/AA
(Figure 7D).mammary glands could be the direct consequence of
diminished NF-B activation, we generated transgenic
mice overexpressing the IB superrepressor in mam- The IkkAA/AA Mutant Phenotype Is Rescued
by a Cyclin D1 Transgenemary epithelium (Figure 7A). This IB mutant contains
alanines instead of serines at positions 32 and 36 and The results presented above suggested that the defect
in lobuloalveolar development in IkkAA/AA mammaryis no longer sensitive to IKK (DiDonato et al., 1997). A
similar construct was used to inhibit NF-B activity in glands is the result of a failure to properly induce cyclin
D1 in response to activation of RANK or other receptors.thymocytes (Hettmann et al., 1999). Of the two lines
of MMTV-IbA32/36 transgenic mice that were analyzed, If this hypothesis is correct, restoration of cyclin D1
expression in IkkAA/AA mammary glands should sup-females of line 13 exhibited a lactation defect similar to
IkkAA/AA mice, resulting in death of all newborns within press the developmental defect and restore normal lac-
tation. We therefore crossed IkkAA/AA males with MMTV-48 hr, while females of line 6 lactated and nursed their
pups. Whole-mount analysis of mammary glands at L1 cyclin D1 transgenic females, which display mammary
IKK and Mammary Gland Development
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Figure 4. Defective Cyclin D1 Induction in
IkkAA/AA Mammary Glands
(A) Cyclin D1 immunostaining. Paraffin sec-
tions of P10 wt and mutant mammary glands
were stained with anti-cyclin D1 antibody.
Positive cells were visualized with Cyanine 3
(red). Nuclei were counter-stained with DAPI
(blue).
(B) Western blot analysis of cyclin D1 expres-
sion in wt and IkkAA/AA mammary glands.
CK18 was used as an epithelial cell marker.
Average relative expression levels are indi-
cated below with wt given an arbitrary value
of 1.00.
gland hyperplasia and increased susceptibility to de- press the lactation defect even after the first pregnancy
(data not shown). Whole-mount analysis of mammaryvelopment of breast tumors (Wang et al., 1994).
Ikk/AAMMTV-cyclin D1 heterozygotes were selected glands at L1 validated these results and revealed resto-
ration of normal lobuloalveolar development by theand intercrossed to generate IkkAA/AAMMTV-cyclin D1
homozygous females, which were mated and analyzed MMTV-cyclin D1 transgene (Figure 8A).
Immunoblot analysis indicated that expression of thefor lactation and mammary gland development. Expres-
sion of the MMTV-cyclin D1 transgene in the IkkAA/AA MMTV-cyclin D1 transgene in the wt background re-
sulted in only a modest elevation in cyclin D1, whereasgenetic background was sufficient to completely sup-
Figure 5. Defective NF-B Activation in
IkkAA/AA Mammary Glands during Pregnancy
(A) NF-B DNA binding activity in wt and
IkkAA mammary glands was examined using
whole-cell extracts and EMSA. NF-1 DNA
binding activity was determined to control for
extract quality and loading
(B) Western blot analysis of NF-B proteins.
Whole-cell extracts of wt and mutant mam-
mary glands at P10 were analyzed by immu-
noblotting for expression of RelA (p65), RelB,





The results described above define a signaling pathway
initiated by binding of RANKL to its receptor, RANK,
that culminates in the induction of cyclin D1 in mammary
gland epithelial cells (Figure 8D). This pathway, com-
posed of at least six components acting in a linear cas-
cade: RANKL, RANK, IKK, IB, NF-B, and cyclin D1,
is fully supported by genetic analysis, which demon-
strates its key role in controlling proliferation of the mam-
mary epithelium during pregnancy. The IKK subunit
of the IKK complex is the central intermediate in this
pathway, responsible for cell-type-specific activation of
NF-B in response to RANK signaling. Remarkably,
IkkAA/AA mice are phenotypically normal, relatively
healthy, and fertile. The only perturbations found to be
caused by this mutation, which renders IKK inactivat-
able, are the defect in mammary gland development
described herein and a partial defect in B cell maturation
and lymphoid organ development described elsewhere
(Senftleben et al., 2001b). Importantly, IkkAA/AA mice do
not display any of the morphogenetic defects caused
by complete absence of IKK (Hu et al., 1999; Takeda
et al., 1999) or the marked sensitivity to TNF-induced
apoptosis and deficient innate immune defenses caused
by IKK ablation (Li et al., 1999a, 1999b; Senftleben et
al., 2001a; Tanaka et al., 1999). The IkkAA mutation does
not interfere with NF-B activation by TNF in mammary
epithelial cells or in response to TNF, IL-1, or endotoxin
in other cell types. The importance of these results is
3-fold. First, they establish a well-defined signaling path-
way, fully supported by genetic analysis, which controls
an organogenic process in mammals. Second, with the
recent demonstration of cyclin D1 requirement for breast
carcinogenesis (Yu et al., 2001) and the highly specific
and relatively mild pathology caused by the IkkAA muta-
tion, the present results raise the possibility of devel-
oping specific therapies for breast cancer that should
be relatively free of toxic side effects. Third, the new
results demonstrate that IKK and IKK can be differen-
tially deployed by different members of the TNF and
TNFR families to induce IB phosphorylation and NF-
B activation.
Figure 6. Defective NF-B Activation by RANKL in IkkAA/AA Mam-
mary Epithelial Cells
RANK, NF-B and the Control of Mammary(A) Northern blot analysis of RANKL expression in wt and mutant
Gland Developmentmammary glands at different time points.
The genetic control of organogenesis has been exten-(B) RT-PCR analysis of RANK expression in two different batches
of cultured mammary epithelial cells. IKK was used as loading sively studied in organisms such as C. elegans and D.
control. melanogaster, where one of the major signaling path-
(C) NF-B activation in response to RANKL or TNF. Primary cultures ways controlling tissue development is the Ras-MAP
of wt or mutant mammary epithelial cells were stimulated with
kinase pathway activated by receptor tyrosine kinasesmTNF (20 ng/ml) or mRANKL (100 ng/ml) for the indicated times.
(RTKs) (Sternberg and Han, 1998; Wassarman et al.,Nuclear extracts were prepared and the levels of NF-B and NF-1
1995). Given the general importance of RTK signaling,DNA binding activities were measured by EMSA.
(D) IKK activation by RANKL or TNF. Cultured mammary epithelial it was somewhat surprising when a member of the TNF
cells were treated as above and at the indicated time points, the family, RANKL, and its receptor, RANK, were found to
IKK complex immunoprecipitated with anti-IKK and kinase activity play a critical role in formation of the lobuloalveolar tree
assayed as usual.
of the mammary epithelium (Fata et al., 2000). The IkkAA
mutation causes the same defect in mammary gland
development as the ablation of either RANK or RANKL
(Fata et al., 2000). In all three cases, the defect is re-its expression in the IkkAA/AA background restored cyclin
D1 expression to normal levels (Figure 8B). However, stricted to growth of the lobuloalveolar network during
pregnancy. The IkkAA mutation also results in defectivethe MMTV-cyclin D1 transgene did not restore NF-B
activity (Figure 8C). NF-B activation in mammary epithelial cells during
IKK and Mammary Gland Development
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Figure 7. Mammary Specific Expression of the IB Superrepressor Retards Lobuloaleveolar Development
(A) IBA32/36 was tagged with the HA epitope, and cloned downstream to the MMTV promoter. Reg, regulatory domain; ANK, ankyrin repeats.
(B) Whole-mount analysis of wt and transgenic mammary glands at L1.
(C) PCR analysis of transgene DNA. GAPDH was used as a control.
(D) Immunoblot analysis of transgene and cyclin D1 expression in wt and transgenic mammary glands. Extracts of L1 mammary glands were
immunoblotted with anti-HA and anti-cyclin D1 antibodies.
pregnancy and in response to RANKL application. Fur- cell-type-specific expression of the IB superrepres-
sor, results in decreased expression of cyclin D1. Mostthermore, the specific inhibition of NF-B in mammary
epithelial cells via targeted expression of the IB super- importantly, restoration of cyclin D1 to its normal level
completely suppresses the mammary gland defect inrepressor also prevents expansion of the lobuloalveolar
tree. It therefore follows that RANK signaling controls IkkAA/AA mice.
Whereas the results described above illustrate themammary gland development through an IKK-depen-
dent NF-B activation pathway. However, the IkkAA mu- existence of a linear signaling cascade through which
RANKL activates IKK and NF-B to induce cyclin D1tation does not result in osteopetrosis or any obvious
effects on T cell development, which were observed in in mammary epithelial cells (Figure 8D), this pathway is
likely to be subjected to more intricate regulation. ForRank/ and Rankl/ mice (Kong et al., 1999).
Our results also establish the role of NF-B in control- instance, the synthesis of RANKL in mammary epithelial
cells is probably regulated by hormonal cues and cell-ling proliferation of the mammary epithelium. Although
experiments performed in transformed cell lines have cell interactions (Fata et al., 2000). RANKL expression
may also be subjected to negative feedback from NF-suggested that cyclin D1 may be an NF-B target gene
(Guttridge et al., 1999; Hinz et al., 1999), the experiments B, as suggested by its elevated expression in IkkAA/AA
mammary glands and transient expression in wt glands.described above establish a clear and positive in vivo
link between NF-B and the cell cycle machinery. Pre- NF-B activity itself is also under negative regulation and
the cyclin D1 promoter contains multiple cis elements,viously, the loss of RANK signaling was suggested to
cause a modest increase in apoptosis of mammary epi- including an AP-1 site, that allow the integration of addi-
tional signaling cascades, such as those activated bythelial cells (Fata et al., 2000). However, we failed to
detect elevated apoptosis in IkkAA/AA mammary glands RTKs (Albanese et al., 1995).
during pregnancy. Increased proliferation of the mam-
mary epithelium was seen in transplanted mammary The Many Functions of IKK
Structurally and biochemically, IKK is very similar toglands derived from IB-deficient mice (Brantley et al.,
2001), thereby lending support to the role of NF-B in IKK (Rothwarf and Karin, 1999). It was therefore a sur-
prise when IKK-deficient cells and mice were found tostimulating the proliferation of this tissue. The inhibition
of NF-B activation, either by the IkkAA mutation or via have rather minor defects in NF-B activation in re-
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al., 2001b), p52 is only a minor NF-B component in
mammary epithelial cells. Second, no lactation defects
were reported for NF-B2 deficient mice (Caamano et
al., 1998; Franzoso et al., 1998). Most likely, the prolifera-
tion of mammary epithelial cells and cyclin D1 induction
during pregnancy depend on the classical NF-B activa-
tion pathway. Indeed, loss of IB results in increased
growth of the mammary epithelium (Brantley et al., 2001)
and expression of the IB superrepressor phenocopies
the IkkAA mutation. Thus, IKK has a third essential
function, the phosphorylation of IB in response to
specific signals. Although IKK was anticipated to be
an IB kinase, the finding that its kinase activity is re-
quired for NF-B activation only in response to distinct
stimuli is novel.
Biochemical analysis of HeLa and Jurkat cells re-
vealed that the IKK complex is composed of IKK:IKK
heterodimers, which are assembled into a heterotet-
ramer through IKK-mediated dimerization (Miller and
Zandi, 2001; Rothwarf and Karin, 1999). Given the tight
interaction between IKK and IKK and their strong
autophosphorylation, it is counterintuitive that the two
catalytic subunits can be differentially activated. Yet,
the present results strongly suggest that in mammary
epithelial cells, IKK and IKK are differentially regu-
lated. Whereas IkkAA/AA cells show normal IKK and NF-
B activation in response to TNF, presumably through
IKK, they are nonresponsive to RANKL. Thus, IKK
rather than IKK is required for NF-B activation by this
TNF family member. The simplest mechanism that could
account for differential IKK and IKK activation would
entail the existence of two separate IKK complexes that
could arise from the disproportional expression of IKK
or IKK. So far, however, the relative expression of IKK
in mammary epithelial cells does not seem different from
that in mouse fibroblasts (unpublished results). AnotherFigure 8. Rescue of the IkkAA/AA Mammary Gland Defect by a Cyclin
D1 Transgene possible mechanism may entail the existence of two
IKK-kinases, one involved in IKK activation by TNF,(A) Whole-mount analysis of L1 mammary glands from littermate
females that are either Ikk/ or IkkAA/AA with or without an MMTV- IL-1, or endotoxin, and the other responsible for IKK
cyclin D1 transgene. activation by RANKL. It was previously thought that NIK
(B) Immunoblot analysis of cyclin D1 expression in extracts of L1 might represent a general IKK-kinase (Woronicz et al.,
mammary glands. 1997). However, the recent knockout of the Nik gene
(C) NF-B DNA binding activity in whole-cell extracts of P10 mam-
demonstrated that it is not required for NF-B activationmary glands from wt, IkkAA/AA, and IkkAA/AA carrying the MMTV-
by most stimuli with the exception of lymphotoxin cyclin D1 transgene.
(LT), a member of the TNF family (Yin et al., 2001). We(D) Schematic illustration of the signaling pathway that controls
the proliferation of the mammary epithelium during pregnancy. The recently presented evidence that NIK may be a specific
second arrow leading to cyclin D1 indicates additional signaling IKK activator (Senftleben et al., 2001b). Although Nik/
pathways that can regulate cyclin D1 expression. mice were reported to exhibit normal lactation (Yin et
al., 2001), aly mice, which carry a point mutation in the
Nik gene that interferes with kinase activation (Shinkura
sponse to proinflammatory stimuli in face of the major et al., 1999), exhibit a mild defect in mammary gland
defect caused by the absence of IKK (Rothwarf and development (Nishimura et al., 2000). Thus, it is possible
Karin, 1999). Although IKK is essential for epidermal that a NIK-like kinase may be involved in IKK activation
differentiation (Hu et al., 1999; Takeda et al., 1999), this in mammary epithelial cells in response to RANK sig-
function does not depend on its protein kinase activity naling.
or NF-B (Hu et al., 2001). Recently, IKK was found to Although the details of IKK activation by any one stim-
have a second function that depends on its protein ki- ulus, including TNF, remain to be elucidated, the pres-
nase activity — the processing of NF-B2 p100 to the ent results clearly demonstrate that IKK and IKK differ
mature p52 DNA binding subunit (Senftleben et al., in their responsiveness to upstream stimuli. These differ-
2001b). Although IKK kinase activity is also required ences can be utilized in the design of therapeutically
for p100 processing in mammary epithelial cells, it is useful IKK inhibitors. While selective IKK inhibition is
unlikely that a p52 deficiency accounts for the defect in expected to inhibit inflammatory responses, it should
mammary gland development. First, unlike B cells where also block innate immunity and sensitize various cells to
TNF-induced apoptosis (Li et al., 1999a, 1999b; Senft-it is a relatively abundant NF-B protein (Senftleben et
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secondary antibody. The antigen antibody complexes were conju-leben et al., 2001a). A selective IKK inhibitor, on the
gated to horseradish peroxidase by the Elite ABC Kit (Vector Labora-other hand, is expected to inhibit B cell maturation and
tories) and visualized with Cyanine 3 using the TSA Fluorescenceproliferation of mammary epithelial cells, but leave in-
System (NEN Life Science Products). Images were captured with a
nate and T cell-mediated adaptive immunity intact. Such DeltaVision deconvolution microscope (Applied Precision, Inc.).
an inhibitor should not sensitize cells to TNF-induced Data sets were deconvolved and analyzed using SoftWorx software
(Applied Precision, Inc) on a Silicon Graphics Octane workstation.apoptosis. Given the common occurrence of constitu-
tive NF-B in breast tumors (Cogswell et al., 2000; Nak-
Mammary Gland Transplantation and Primary Culturesshatri et al., 1997; Sovak et al., 1997) and their reliance
Approximately 1 mm3 mammary tissue fragments were isolated fromon cyclin D1 (Yu et al., 2001), it may be possible to
8-week-old nulliparous donors and implanted into cleared fat pads
treat breast cancer with selective IKK inhibitors without of bilateral #4 mammary glands of 3-week-old Rag1/ hosts (Jack-
causing the severe side effects associated with inhibi- son Laboratories). Hosts were mated 9 weeks later and transplants
tion of IKK. were isolated for analysis on day of delivery. The #3 mammary
glands were taken from the donor for internal controls.
Mammary glands #3, #4, and #5 were taken from 14–15 day preg-Experimental Procedures
nant mice, and epithelial cell fractions were prepared as described
(Pullan and Streuli, 1997; Seagroves et al., 1998). Cells were culturedMice
approximately 3 days before stimulation with mTNF (20 ng/ml) orA genomic IKK clone (Hu et al., 1999) was used to construct the
mRANKL (R&D Systems, 100 ng/ml). Nuclear extracts were preparedIkkAA targeting vector. A 6.0 kb BamHI fragment containing 1.3
for gel shift assay.and 4.7 kb of DNA upstream and downstream to codons 176/180,
respectively, was subcloned into pUC18. A NotI site was introduced
IB Kinase and Gel Shift Assaysby site-directed mutagenesis into the seventh intron using the Quik-
IKK immunecomplex kinase assay was performed as described (Di-Change Mutagenesis Kit (Stratagene) followed by insertion of a NotI
Donato et al., 1997) except that an IKK antibody (PharMingen) wasfragment containing a Neor cassette flanked by LoxP sites. Serines
used for immunoprecipitation. Electrophoretic mobility shift assays176 and 180 were converted to alanines (QuikChange Mutagenesis
of NF-B and NF-1 were previously described (Senftleben et al.,Kit; primer sequences available upon request), introducing a new
2001a, 2001b).Eco47III site. A 200 bp BclI-NcoI fragment covering the mutagenized
region was sequenced to exclude other mutations and swapped
Northern and Western Blot Analysesback into the clone containing the 6.0 kb genomic DNA with the
Total RNA was isolated from #4 mammary glands using RNeasy KitNeor cassette. The targeting vector was linearized by HindIII and
(Qiagen). Twenty g samples were analyzed by Northern hybridiza-electroporated into ES cells. Approximately 150 G418-resistant
tion after gel separation using QuikHyb Hybridization Solution (Stra-clones were collected and screened by PCR to identify homologous
tagene) and 32P-labeled probes (Prime It II, Stratagene). Protein ly-integrants at the IKKa locus (Primers; p309: 5-ccggaagctactcaa
sates were prepared from #4 mammary glands and analyzed bycaaaccag; p5Neo: 5-ccatcatggctgatgcaa). Six IkkAA positive
immunoblotting (Hu et al., 1999), except that the IKK antibody wasclones were identified, confirmed by Eco47III digestion, and electro-
from Imgenex and CK18 antibody was from Progen.porated with a Cre expression vector to delete the Neor cassette.
Clones lacking the Neor cassette were identified by PCR (Primers;
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